Found: 8
Select item for more details and to access through your institution.
Clinical coding data algorithm to categorize type of gastrointestinal bleeding as a primary reason for massive transfusion: results from the Australian and New Zealand Massive Transfusion Registry.
- Published in:
- Vox Sanguinis, 2019, v. 114, n. 8, p. 853, doi. 10.1111/vox.12840
- By:
- Publication type:
- Article
Complications of cold versus hot snare polypectomy of 10–20 mm polyps: A retrospective cohort study.
- Published in:
- JGH Open, 2020, v. 4, n. 2, p. 172, doi. 10.1002/jgh3.12243
- By:
- Publication type:
- Article
Diagnostic Accuracy of Endoscopic Trimodal Imaging and Chromoendoscopy for Lesion Characterization in Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 12, p. 1586, doi. 10.1093/ecco-jcc/jjz074
- By:
- Publication type:
- Article
Diagnostic Accuracy of Endoscopic Trimodal Imaging and Chromoendoscopy for Lesion Characterization in Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 12, p. 1438, doi. 10.1093/ecco-jcc/jjy129
- By:
- Publication type:
- Article
Critical peptic ulcer bleeding requiring massive blood transfusion: outcomes of 270 cases.
- Published in:
- Internal Medicine Journal, 2021, v. 51, n. 12, p. 2042, doi. 10.1111/imj.15009
- By:
- Publication type:
- Article
Body mass index is inversely associated with capillary ketones at the time of colonoscopy: Implications for SGLT2i use.
- Published in:
- Clinical Endocrinology, 2022, v. 96, n. 4, p. 549, doi. 10.1111/cen.14621
- By:
- Publication type:
- Article
Response to Comment on Hamblin et al. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes. Diabetes Care 2021;44:e124-e126.
- Published in:
- Diabetes Care, 2022, v. 45, n. 1, p. e17, doi. 10.2337/dci21-0048
- By:
- Publication type:
- Article
Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- letter